13F Insight
DOSSIER · 13F-HR · Q2 2026

Affinity Asset Advisors, LLC

$2.2B in tracked AUM across 113 positions as of Q2 2026.

AA
CIK 0001773195 · last filed Jun 30, 2026
Total AUM
$2.2B
as of Q2 2026
Holdings
113
—
positions
Whale Score
58
58
tracked
Activity
—
no data
changes this Q
AI Analysis · Q2 2026

Affinity Asset Advisors, LLC filed its latest 13F-HR for Q2 2026. See the latest holdings and position changes below.

Quarter at a glance — Q2 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q2 2026.

#HoldingValueSharesWeight
01
G76279101
ROIVANT SCIENCES LTD
$133M3.8M6.0%02
APGE
APOGEE THERAPEUTICS INC
$131M987K5.9%03
SYRE
SPYRE THERAPEUTICS INC
$114M1.3M5.1%04
XENE
XENON PHARMACEUTICALS INC
$96M1.6M4.4%05
ERAS
ERASCA INC
$96M5.3M4.3%06
G01767105
ALKERMES PLC
$72M1.4M3.3%07
INSM
INSMED INC
$69M650K3.1%08
MRNA
MODERNA INC
$68M975K3.1%09
PRAX
PRAXIS PRECISION MEDICINES I
$62M185K2.8%10
ORKA
ORUKA THERAPEUTICS INC
$56M590K2.5%

Filing history

2026Q2Jun 30
$2.2B▲ 14.3%
113 positionsView →2026Q1Mar 31
$1.9B▲ 10.3%
105 positionsView →2025Q4Dec 31
$1.8B▲ 145.4%
95 positionsView →2025Q3Sep 30
$715M▼ 2.3%
69 positionsView →2025Q2Jun 30
$732M▲ 0.6%
91 positionsLocked2025Q1Mar 31
$728M▼ 2.4%
68 positionsLocked2024Q4Dec 31
$746M▲ 1.8%
85 positionsLocked2024Q3Sep 30
$733M▼ 15.5%
86 positionsLocked2024Q2Jun 30
$868M▲ 7.4%
98 positionsLocked2024Q1Mar 31
$808M▲ 47.5%
95 positionsLocked2023Q4Dec 31
$548M▲ 54.0%
82 positionsLocked2023Q3Sep 30
$356M▲ 24.0%
81 positionsLocked
Showing 12 of 23